CCN-Based Therapeutic Peptides Modify Pancreatic Ductal Adenocarcinoma Microenvironment and Decrease Tumor Growth in Combination with Chemotherapy
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CCN-Based Therapeutic Peptides Modify Pancreatic Ductal Adenocarcinoma Microenvironment and Decrease Tumor Growth in Combination with Chemotherapy
Authors
Keywords
-
Journal
Cells
Volume 9, Issue 4, Pages 952
Publisher
MDPI AG
Online
2020-04-14
DOI
10.3390/cells9040952
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cyr61/CCN1 regulates dCK and CTGF and Causes Gemcitabine Resistant Phenotype in Pancreatic Ductal Adenocarcinoma
- (2019) Gargi Maity et al. MOLECULAR CANCER THERAPEUTICS
- Caught between a “Rho” and a hard place: are CCN1/CYR61 and CCN2/CTGF the arbiters of microvascular stiffness?
- (2019) Brahim Chaqour Journal of Cell Communication and Signaling
- CTGF: A potential therapeutic target for Bronchopulmonary dysplasia
- (2019) Xinbao Wang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- CTGF mediates tumor-stroma interactions between hepatoma cells and hepatic stellate cells to accelerate HCC progression.
- (2018) Yuki Makino et al. CANCER RESEARCH
- Soluble stroma‐related biomarkers of pancreatic cancer
- (2018) Andrea Resovi et al. EMBO Molecular Medicine
- CTGF/CCN2 is an autocrine regulator of cardiac fibrosis
- (2018) Lisa E. Dorn et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Connective tissue growth factor induces renal fibrosis via epidermal growth factor receptor activation
- (2018) Sandra Rayego-Mateos et al. JOURNAL OF PATHOLOGY
- The Extracellular Matrix and Pancreatic Cancer: A Complex Relationship
- (2018) Maximilian Weniger et al. Cancers
- The Paradoxical Web of Pancreatic Cancer Tumor Microenvironment
- (2018) Kelly J. Lafaro et al. AMERICAN JOURNAL OF PATHOLOGY
- Deletion of connective tissue growth factor ameliorates peritoneal fibrosis by inhibiting angiogenesis and inflammation
- (2017) Naohiro Toda et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Inhibition of CTGF ameliorates peritoneal fibrosis through suppression of fibroblast and myofibroblast accumulation and angiogenesis
- (2017) Norihiko Sakai et al. Scientific Reports
- Human pancreatic cancer progression: an anarchy among CCN-siblings
- (2016) Sushanta K. Banerjee et al. Journal of Cell Communication and Signaling
- Cell surface receptors for CCN proteins
- (2016) Lester F. Lau Journal of Cell Communication and Signaling
- Cellular and molecular actions of CCN2/CTGF and its role under physiological and pathological conditions
- (2015) Satoshi Kubota et al. CLINICAL SCIENCE
- Stromal biology and therapy in pancreatic cancer: a changing paradigm
- (2015) Albrecht Neesse et al. GUT
- Bevacizumab-Induced Inhibition of Angiogenesis Promotes a More Homogeneous Intratumoral Distribution of Paclitaxel, Improving the Antitumor Response
- (2015) M. Cesca et al. MOLECULAR CANCER THERAPEUTICS
- Balanced regulation of the CCN family of matricellular proteins: a novel approach to the prevention and treatment of fibrosis and cancer
- (2015) Bruce L. Riser et al. Journal of Cell Communication and Signaling
- Treatment with the Matricellular Protein CCN3 Blocks and/or Reverses Fibrosis Development in Obesity with Diabetic Nephropathy
- (2014) Bruce L. Riser et al. AMERICAN JOURNAL OF PATHOLOGY
- Overexpression of CCN3 Inhibits Inflammation and Progression of Atherosclerosis in Apolipoprotein E-Deficient Mice
- (2014) Jun Liu et al. PLoS One
- CTGF antagonism with mAb FG-3019 enhances chemotherapy response without increasing drug delivery in murine ductal pancreas cancer
- (2013) A. Neesse et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CCN2/Connective Tissue Growth Factor Is Essential for Pericyte Adhesion and Endothelial Basement Membrane Formation during Angiogenesis
- (2012) Faith Hall-Glenn et al. PLoS One
- CCN1 promotes tumorigenicity through Rac1/Akt/NF-κB signaling pathway in pancreatic cancer
- (2012) Xuqing Wang et al. TUMOR BIOLOGY
- Desmoplasia in Pancreatic Cancer. Can We Fight It?
- (2012) E. E. Merika et al. Gastroenterology Research and Practice
- A novel method for quantification of gemcitabine and its metabolites 2′,2′-difluorodeoxyuridine and gemcitabine triphosphate in tumour tissue by LC–MS/MS: comparison with 19F NMR spectroscopy
- (2011) Tashinga E. Bapiro et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Targeting angiogenesis with compounds from the extracellular matrix
- (2011) Dorina Belotti et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Cyr61/CCN1 signaling is critical for epithelial-mesenchymal transition and stemness and promotes pancreatic carcinogenesis
- (2011) Inamul Haque et al. Molecular Cancer
- Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets
- (2011) Joon-Il Jun et al. NATURE REVIEWS DRUG DISCOVERY
- Guidelines for the welfare and use of animals in cancer research
- (2010) P Workman et al. BRITISH JOURNAL OF CANCER
- CCN3/CCN2 regulation and the fibrosis of diabetic renal disease
- (2010) Bruce L. Riser et al. Journal of Cell Communication and Signaling
- CCN3 (NOV) Is a Negative Regulator of CCN2 (CTGF) and a Novel Endogenous Inhibitor of the Fibrotic Pathway in an in Vitro Model of Renal Disease
- (2009) Bruce L. Riser et al. AMERICAN JOURNAL OF PATHOLOGY
- The Role of Tumor Cell-Derived Connective Tissue Growth Factor (CTGF/CCN2) in Pancreatic Tumor Growth
- (2009) K. L. Bennewith et al. CANCER RESEARCH
- Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
- (2009) K. P. Olive et al. SCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started